Estrone b-D-glucuronide sodium salt

CAS : 15087-01-1

Ref. 3D-ME11970

Informations sur le produit

• Nom: Estrone b-D-glucuronide sodium salt
• Synonymes: E3G, Estrone-3-(Beta-D-Glucuronide Sodium Salt), Estrone-3-Glucuronide Sodium Salt, Estrone Beta-D-Glucuronide Sodium Salt, Estrone Glucuronide, Sodium Salt, 3-Hydroxy-1,3,5[10]-Estratrien-17-One 3-Glucuronide Sodium Salt, 1,3,5(10)-Estratrien-3-Ol-17-One Glucosiduronate, Sodium Salt, 1,3,5(10)-Estratrien-3-Ol-17-One 3(O->1Beta)-D-Glucopyranosiduronic Acid Sodium Salt, sodium (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy}tetrahydro-2H-pyran-2-carboxylate (non-preferred name)

Description

Estrone b-D-glucuronide sodium salt (EBGG) is a steroid hormone that is synthesized in the ovaries. EBGG has been shown to be effective against bacterial vaginosis and polycystic ovarian syndrome. It is not active against other types of vaginal infections, such as yeast vaginitis or candida vulvovaginitis. EBGG has also been used to treat infertility in women, with promising results. The compound may work by increasing the metabolic rate and suppressing the production of progesterone and testosterone, which are important for fertility. EBGG binds to an estrogen receptor on cells in the uterus, stimulating the growth of uterine tissue and increasing blood flow to the uterus. EBGG binds to a specific site on the surface of cells called a monoclonal antibody, which can inhibit cell proliferation. This binding leads to an increase in progesterone receptor expression on uterine cells and inhibits the production of progesterone receptors on breast cancer

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 468.47 g/mol
• Formule: C₂₄H₂₉O₈·Na
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder